New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
10:25 EDTDRRX, DRRX, PCRX, PCRXSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Durect's (DRRX) Posidur for post-operative pain, its safety and whether it could be disruptive to Pacira Pharmaceuticals (PCRX) on an Analyst/Industry conference call to be held on January 8 at 11 am.
News For DRRX;PCRX From The Last 14 Days
Check below for free stories on DRRX;PCRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
14:16 EDTPCRXPacira Pharmaceuticals price target raised to $111 from $86 at Brean Capital
Subscribe for More Information
06:45 EDTPCRXPacira Pharmaceuticals reports Q2 Exparel net sales $44.9M
Subscribe for More Information
06:45 EDTPCRXPacira Pharmaceuticals reports Q2 EPS (14c), consensus (21c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use